Inclusion body myopathy with Paget disease of bone and frontotemporal dementia: genes and variants
Explore variant evidence for Inclusion body myopathy with Paget disease of bone and frontotemporal dementia across 2 analyzed proteins (VCP, HNRNPA1). Linked ClinVar records include 31 pathogenic or likely pathogenic variants, 127 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
VCP: Transitional endoplasmic reticulum ATPase
It uses ATP to extract ubiquitinated proteins from complexes or membranes for recycling or degradation and is central to proteostasis, ER-associated degradation, and autophagy. Dominant pathogenic variants cause multisystem proteinopathy with inclusion-body myopathy, Paget disease, frontotemporal dementia, or ALS.
31 ClinVar pathogenic / likely pathogenic and 138 uncertain variants in VCP have source records linked to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia. Association strength is not clinical gene validity.
HNRNPA1: Heterogeneous nuclear ribonucleoprotein A1
It regulates pre-mRNA splicing, RNA transport, translation, and stress-granule dynamics through RNA binding and reversible self-assembly. Rare pathogenic variants can cause multisystem proteinopathy, amyotrophic lateral sclerosis, or related neuromuscular degeneration through altered RNA and protein homeostasis.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in HNRNPA1 have source records linked to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| VCP R159C | 159 | Pathogenic / likely pathogenic (★★) | |
| VCP R191Q | 191 | Pathogenic / likely pathogenic (★★) | |
| VCP R155S | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R155G | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R155C | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R155P | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R155L | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R155H | 155 | Pathogenic / likely pathogenic (★★) | |
| VCP R159S | 159 | Pathogenic / likely pathogenic (★★) | |
| VCP R159G | 159 | Pathogenic / likely pathogenic (★★) | |
| VCP R191P | 191 | Pathogenic / likely pathogenic (★★) | |
| VCP R159H | 159 | Pathogenic / likely pathogenic (★★) | |
| VCP R93C | 93 | Pathogenic / likely pathogenic (★★) | |
| VCP G156S | 156 | Pathogenic / likely pathogenic (★★) | |
| VCP G111S | 111 | Pathogenic / likely pathogenic (★★) | |
| VCP P137L | 137 | Pathogenic / likely pathogenic (★★) | |
| VCP E185K | 185 | Pathogenic / likely pathogenic (★★) | |
| VCP R256G | 256 | Pathogenic / likely pathogenic (★★) | |
| VCP N91Y | 91 | Pathogenic / likely pathogenic (★) | |
| VCP N91K | 91 | Pathogenic / likely pathogenic (★) | |
| VCP R95G | 95 | Pathogenic / likely pathogenic (★) | |
| VCP R95S | 95 | Pathogenic / likely pathogenic (★) | |
| VCP R89Q | 89 | Pathogenic / likely pathogenic (★) | |
| VCP R95H | 95 | Pathogenic / likely pathogenic (★) | |
| VCP G97E | 97 | Pathogenic / likely pathogenic (★) | |
| VCP D98E | 98 | Pathogenic / likely pathogenic (★) | |
| VCP G157R | 157 | Pathogenic / likely pathogenic (★) | |
| VCP M158V | 158 | Pathogenic / likely pathogenic (★) | |
| VCP P188H | 188 | Pathogenic / likely pathogenic (★) | |
| VCP G128S | 128 | Pathogenic / likely pathogenic (★) | |
| VCP I216M | 216 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| VCP R93H | 93 | Conflicting reports (★) | +7: 6 other pathogenic changes within 3 positions; R93C at the same position is pathogenic; seen in 6.8e-06 of gnomAD DNA copies; REVEL 0.881 | |
| VCP R89W | 89 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R89Q at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 | |
| VCP R95P | 95 | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; R95G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 | |
| VCP G156V | 156 | Uncertain (★) | +6: 13 other pathogenic changes within 3 positions; G156S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 | |
| VCP P188L | 188 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; P188H at the same position is pathogenic; seen in 5.5e-06 of gnomAD DNA copies; REVEL 0.763 |
Which prediction tools work for Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 95 out of 100
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 83 out of 100
- SIFT: 75 out of 100
Same protein, different disease
- Childhood Onset VCP-related Neurodevelopmental Disorder also has ClinVar records linked to VCP variants; they fall mostly in different places as the Inclusion body myopathy with Paget disease of bone and frontotemporal dementia variants (4 pathogenic / likely pathogenic).
Diseases related to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia
- Amyotrophic lateral sclerosis, also linked to HNRNPA1 and VCP
- Charcot-Marie-Tooth disease, also linked to VCP
- Alzheimer disease, also linked to VCP
- Frontotemporal dementia and/or amyotrophic lateral sclerosis, also linked to VCP
- Chronic progressive multiple sclerosis, also linked to HNRNPA1
- Childhood Onset VCP-related Neurodevelopmental Disorder, also linked to VCP
- Relapsing remitting multiple sclerosis, also linked to HNRNPA1
Frequently asked questions
Which genes have records linked to Inclusion body myopathy with Paget disease of bone and frontotemporal dementia?
This view contains 2 analyzed proteins: VCP, HNRNPA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 31 pathogenic or likely pathogenic variants, 127 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 5 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 177 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center